Novocure stock surged Wednesday after its medtech device nearly doubled the length of time patients with brain tumors lived before worsening.

The post Novocure Surges And Flashes A Bullish Sign On Promising Results For Brain Cancer Treatment appeared first on Investor’s Business Daily.